Infliximab is an Appropriate Second‐Line Therapy in Infants with Steroid Refractory Pyoderma Gangrenosum

Added 126 days ago (18.01.2022)
Authors: LM Lesmeister, J Peitz, JC von Kleist‐Retzow, MA Lee‐Kirsch, A Torrelo, I Tantcheva‐Poor, IJ Broekaert
Read article